News

Kmart working with Diplomat Specialty Pharmacy to offer specialty meds

BY Antoinette Alexander

HOFFMAN ESTATES, Ill. — Kmart Pharmacy has announced that it is working with Diplomat Specialty Pharmacy to give Kmart customers and Shop Your Way members access to specialty medications.

By 2018, specialty medications are projected to account for more than 51% of sales within the top 100 prescription products. Through this new agreement with Diplomat Pharmacy, Kmart is looking to offer a new level of service and convenience to meet the needs of the growing specialty medication population. 
 

“We understand that when patients are dealing with a chronic or complex health condition they need an extra level of care,” stated Mark Panzer, president of Pharmacy for Sears Holdings. “By partnering with Diplomat Pharmacy, Kmart Pharmacy is able to provide a highly trained team to support medication therapy and comprehensive care management to better serve our specialty pharmacy members.”
 

In addition to HIV, Crohn’s, anemia and Hepatitis C, Kmart Pharmacies will also offer specialty medications to treat conditions such as cystic fibrosis, growth hormone, multiple sclerosis, osteoporosis, renal, rheumatoid arthritis, and transplants. In addition, patients will have access to patient care coordinators familiar with their medical files, specialized injection training (for patients requiring this service), and manufacturer co-payment support cards for eligible patients.
 

“Working with Kmart Pharmacies means millions more will have access to specialty drugs through the convenience of their local Kmart pharmacy,” stated Ela Lourido, director of Retail Specialty Network for Diplomat. “It also means patients will have access to teams of specialists who understand their unique needs. The big winner in this is the specialty drug patient who now has a full team of healthcare professionals at their disposal, working together to ensure the best outcome.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Two Brunet Target affiliated pharmacies open in Quebec

BY Antoinette Alexander

MONTREAL, Quebec — Target has announced that two Brunet Target affiliated pharmacies are now open at the Brossard and Sainte-Dorothée Target store locations.

A total of 18 pharmacies operated by pharmacist-owners affiliated with Brunet will open at Target stores across Québec in 2014. 

“Healthcare is an integral part of the Target brand experience and the newly opened Brunet Target affiliated pharmacies enable us to deliver superior, patient-focused healthcare to our guests across Quebec,” stated Jeff May, director, healthcare operations, Target Canada. “Target is proud of its unique co-branding concept with Brunet, a well-established and highly respected banner in Quebec, which will enhance the guest experience.”

Target has developed a franchise model for the Canadian market, and a similar model will be used in Quebec with Brunet. The pharmacies will carry Target owned brands such as up & up and provide guests with access to prescription, pharmacy and health consultation services. Guests can also access Brunet’s exclusive MaSanté online tool, which provides them with personalized options to access their file online.

The Brunet Target openings follow last year’s announcement of a partnership between Target and Metro Inc.’s subsidiary, McMahon Distributeur pharmaceutique Inc., for the operation of pharmacies at the majority of Target locations across Quebec. Under this agreement, Brunet is responsible for recruiting pharmacists, providing these owner-pharmacists with technology and other patient systems, and providing supply chain and inventory management services.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Target CEO Gregg Steinhafel resigns

BY Antoinette Alexander

MINNEAPOLIS — In the wake of a data breach late last year, Target’s board of directors has announced that Gregg Steinhafel is stepping down as chairman, president and CEO, effective immediately.
 
“Today we are announcing that, after extensive discussions, the board and Gregg Steinhafel have decided that now is the right time for new leadership at Target. Effective immediately, Gregg will step down from his positions as chairman of the Target board of directors, president and CEO.” 

Assuming the role of interim president and CEO is John Mulligan, Target’s CFO. Roxanne Austin, a current member of Target’s board of directors, has been appointed as interim non-executive chair of the board. Both will serve in their roles until permanent replacements are named. Steinhafel has agreed to serve in an advisory capacity during the transition.

 

CFO John Mulligan is named interim president and CEO

“The board is deeply grateful to Gregg for his significant contributions and outstanding service throughout his notable 35-year career with the company. We believe his passion for the team and relentless focus on the guest have established Target as a leader in the retail industry. Gregg has created a culture that fosters innovation and supports the development of new ideas. Under his leadership, the company has not only enhanced its ability to execute, but has broadened its strategic horizons. He also led the company through unprecedented challenges, navigating the financial recession, reacting to challenges with Target’s expansion into Canada, and successfully defending the company through a high-profile proxy battle,” the board stated.
 
The board added, “Most recently, Gregg led the response to Target’s 2013 data breach. He held himself personally accountable and pledged that Target would emerge a better company. We are grateful to him for his tireless leadership and will always consider him a member of the Target family.”
 
 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?